Physician profile
Larry S Fields
NPI 1083612774
$9,376.33
in general payments reported to CMS, 2019-2025
44 companies · $57.79 in 2025
The $57.79 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,976 · 2020: $2,026 · 2021: $2,358 · 2022: $2,904 · 2023: $38.94 · 2024: $14.68 · 2025: $57.79.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $111.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $111.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $3,169.82 | 2020-2024 | |
| Novo Nordisk INC | $997.41 | 2019-2022 | |
| Astrazeneca Pharmaceuticals Lp | $825.64 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $549.26 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $464.30 | 2019-2022 | |
| Pfizer INC. | $336.84 | 2019-2021 | |
| Allergan, INC. | $316.40 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $263.63 | 2019-2021 | |
| Lilly USA, LLC | $257.19 | 2019-2022 | |
| Kowa Pharmaceuticals America, INC. | $213.11 | 2019-2022 | |
| Mylan Specialty L.P. | $207.28 | 2019-2022 | |
| Amarin Pharma, INC. | $199.24 | 2019-2021 | |
| Glaxosmithkline, LLC. | $146.00 | 2019-2021 | |
| Esperion Therapeutics, INC. | $144.07 | 2020-2021 | |
| Sanofi-Aventis U.S. LLC | $143.71 | 2019-2020 |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Larry Fields listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.